Mr Andreas Wallnoefer | Global Head of Prod Development
F Hoffman La Roche Ltd

Andreas joined F. Hoffmann-La Roche after his clinical research fellowship at Leiden University as a Clinical Pharmacologist. He was responsible for clinical “Proof of Concept” studies and later became Clinical Science Leader for Cardiovascular Clinical Development.
Andreas became R&D project leader in 1999 and was appointed in 2002 as Global Head of Exploratory Development Project Leaders and Project Management. In 2007, he became Global Head of Clinical Research & Exploratory Development and successfully built this newly formed function. Under his leadership Discovery Research and Clinical Research became better connected and translational medicine became a key driver to implement the Personalized Healthcare strategy of Roche.
 
In 2009, Andreas was the task force leader for the integration of the clinical development departments of Roche and Genentech after the Genentech acquisition and was subsequently appointed as the new Head of Roche pRED Development. In 2012 he took on, in addition, the role of the Acting Head of the Cardiovascular & Metabolism Disease Therapeutic Area. 
 
A clinical pharmacologist by training with additional degrees in Pharmaceutical Medicine and Business Management (IMD), Andreas earned his Ph.D. at the University of Basel. Prior to Roche, he worked in Cardiovascular Research at Sandoz and pursued post-graduate training in Clinical Pharmacology at the University Hospital Leiden, Netherlands.